Become a member of the RD-Connect Community

…funding period. The new RD-Connect Community is an independent, not-for-profit, international association of individuals and organizations sharing the vision of building an open community that works to improve rare disease…

Read More

FSHD Clinical Trial Updates

Clinical trial updates in FSHD

…is an antisense oligonucleotide against DUX4 that is given by intravenous infusion. We are currently the sole Canadian site for the FORTITUDE study and are excited to open recruitment for

Read More

Identification of pathomechanisms

…support characterization of the disease, unravel the pathogenic mechanisms, identify new therapeutic targets for intervention, and perform preclinical testing where potential therapeutics/targets are identified. The full elucidation of pathomechanisms is…

Read More

Research areas

Researcher using a pipette in a fume hood

Our areas of research Although individually uncommon, rare diseases are so numerous that they collectively affect as many as one person in every 17 – in Canada, about 2 million

Read More

Kelly Ho

…and validate treatments to stabilize the neuromuscular junction in a mouse model of ColQ congenital myasthenic syndrome (ColQ-CMS). She joined the Lochmüller team as a Master’s student in September 2021….

Read More